this presentation contains epidemiology of propane poisoning, kinetics in overdose and clinical effects. in the management mainly focused on methhemoglobinemia.
Brand name : NAMENDA
US FDA Approval :October 2003
NMDA (N-methyl-D-aspartate) receptor antagonist
Indicated for the treatment of moderate to severe Alzheimer’s Disease
Please find the power point on Paracetamol poisoning. I tried to present it on understandable way and all the contents are reviewed by experts and from very reliable references. Thank you
Nitrobenzene Poisoning (A Case Report) Methhemoglobinemia Due to Nitrobenzene...iosrphr_editor
The IOSR Journal of Pharmacy (IOSRPHR) is an open access online & offline peer reviewed international journal, which publishes innovative research papers, reviews, mini-reviews, short communications and notes dealing with Pharmaceutical Sciences( Pharmaceutical Technology, Pharmaceutics, Biopharmaceutics, Pharmacokinetics, Pharmaceutical/Medicinal Chemistry, Computational Chemistry and Molecular Drug Design, Pharmacognosy & Phytochemistry, Pharmacology, Pharmaceutical Analysis, Pharmacy Practice, Clinical and Hospital Pharmacy, Cell Biology, Genomics and Proteomics, Pharmacogenomics, Bioinformatics and Biotechnology of Pharmaceutical Interest........more details on Aim & Scope).
Brand name : NAMENDA
US FDA Approval :October 2003
NMDA (N-methyl-D-aspartate) receptor antagonist
Indicated for the treatment of moderate to severe Alzheimer’s Disease
Please find the power point on Paracetamol poisoning. I tried to present it on understandable way and all the contents are reviewed by experts and from very reliable references. Thank you
Nitrobenzene Poisoning (A Case Report) Methhemoglobinemia Due to Nitrobenzene...iosrphr_editor
The IOSR Journal of Pharmacy (IOSRPHR) is an open access online & offline peer reviewed international journal, which publishes innovative research papers, reviews, mini-reviews, short communications and notes dealing with Pharmaceutical Sciences( Pharmaceutical Technology, Pharmaceutics, Biopharmaceutics, Pharmacokinetics, Pharmaceutical/Medicinal Chemistry, Computational Chemistry and Molecular Drug Design, Pharmacognosy & Phytochemistry, Pharmacology, Pharmaceutical Analysis, Pharmacy Practice, Clinical and Hospital Pharmacy, Cell Biology, Genomics and Proteomics, Pharmacogenomics, Bioinformatics and Biotechnology of Pharmaceutical Interest........more details on Aim & Scope).
this is all medicine are used in anesthesia so as student are in field of anesthesia you can find this attachment, may it will help you to know more about this general anesthetics drugs if you got a questions you contact me inbox
Approach to maternal collapse and cardiac arrest.pptxKTD Priyadarshani
This is a case based discussion on approach to maternal collapse and cardiac arrest. It includes a detailed account on ERC ALS guideline on maternal cardiac arrest and post resuscitation care.
Pelvic Fracture managemnt- Case based discussion .pptxKTD Priyadarshani
A case based approach on the management of a pelvic fracture. it is based on ATLS guideline. A brief account on anaesthetic and orthopedic point of view also included.
This presentation describes cardiac physiology and classification of antiarrhythmics. It also includes a brief account of main drugs of each group including latest drugs like ranolazine, ivabradine and vernakalent.
This presentation describes updated management of thyroid related emergencies. Anaesthetic considerations of myxoedema coma and thyrotoxic crisis is highlighted.
This presentation is based on JBDS and BSPDE guidelines in adult and Paediatric DKA management. A comparison of adult vs paediatric management is included.
This is about emergency approach to a patient presenting with acute severe hemolysis. It mainly describes general approach and how to choose investigations appropriately. In depth discussion about the management of autoimmune haemolytic anaemia with warm antibody, cold antibody, all-immune antibody, drug induced, microangiopathic syndromes- TTP, HUS, DIC, Macrovascular hemolysis, sickle cell disease, thalassemia, G6PD deficiency, Hereditary spherocytosis and paroxysmal nocturnal hemoglobinuria is included.
This presentation describes the epidemiology, initial assessment, investigation and emergency department management of a patient with atrial fibrillation. Some new research evidences are also discussed to answer some dilemmas.
A brief account on major toxidrome and an explanation about how the clinical features occur. anticholinergic, cholinergic, sympathomimetic, opiate, sedative toxidrome and serotonin syndrome and neuroleptic malignant syndrome are explained with the management.
Toxic alcohol includes Methanol, Ethylene Glycol, Isopropyl alcohol. The toxicokinetics, clinical features are explained separately. Pathophysiology of toxic alcohols explained using diagrams. diagnosis can be done using HAGMA, High osmolar gap, UFR and ECG. Management is determined by block metabolism, correct pH and eliminate toxic metabolites.
This presentation includes overview of Sri cyclic antidepressants, its toxicokinetics, toxic mechanism and clinical features. The management is explained in detailed according Resus- RSI- DEAD steps. Main steps includes resuscitation, risk assessment, investigations, supportive therapy, decontamination, antidote- sodium bicarbonate, lipid emulsion and elimination methods.
This presentation is based on SLMA guideline of Snake bite management in 2021. This includes a brief account on Snake identification, clinical features and syndromic approach. management of snake bite is discussed detailed, including AVS therapy, complications and management of cobra, krait, Russel's viper, saw scaled viper, humped nose pit viper, green pit viper bite separately.
The presentation includes epidemiology of poisonous plants, classification based upon latest publication from poison centre- Sri Lanka. It goes in to details of Jatropha circus, Glorriosa superba, Thevetia Peruviana, Datura stramonium, Tabernaemantona dichotomy, Strychnus nut vomica toxicity.
This presentation explains about epidemiology of organophosphate poisoning, the toxic mechanism and pathophysiological basis of clinical features. It briefly outlines diagnosis in an emergency situation and management.
ECG is widely available, non invasive investigation in emergency setting. This presentation describes utility of ECG as a screening tool in an unknown poisoning. It includes toxidromic approach in interpreting ECG to narrow down your differential diagnosis based on published articles.
Presentation includes an account on overview about oral anti diabetics, toxicity of sulfonylureas, biguanides, alpha-glucosidase inhibitors, DPP4 inhibitor, SGLT2 inhibitor and its managemnt.
This presentation includes approach to a patient admitting with calcium channel or beta blocker overdose. Toxic mechanism and clinical features are explained. Management is subdivided to Resuscitation, Risk assessment, supportive care & monitoring, investigations, decontamination, antidote and disposition. Antidotes explained are HEIT therapy, vasopressors, glucagon and lipid emulsion
A brief account on use of bicarbonate in toxicology. It includes use in sodium channel blocker poisoning, serum alkalisation, urine alkalisation and toxic alcohol. Details in to doses and routes also included.
A brief account on Organophosphate poisoning and management practised in Sri Lanka. It includes a description of toxic mechanism, clinical features and management with atropinisation and pralidoxime.
This includes a brief account on epidemiology, pathophysiology, clinical presentation, investigation, treatment, complications and disposition of a patient presenting with acute pancreatitis.
This is based on approach to a patient presenting to emergency department complaining of right hypochondriac pain. It includes anatomy, pathophysiology, epidemiology, clinical assessment, investigation, management, complication and disposition of a biliary infection.
Title: Sense of Smell
Presenter: Dr. Faiza, Assistant Professor of Physiology
Qualifications:
MBBS (Best Graduate, AIMC Lahore)
FCPS Physiology
ICMT, CHPE, DHPE (STMU)
MPH (GC University, Faisalabad)
MBA (Virtual University of Pakistan)
Learning Objectives:
Describe the primary categories of smells and the concept of odor blindness.
Explain the structure and location of the olfactory membrane and mucosa, including the types and roles of cells involved in olfaction.
Describe the pathway and mechanisms of olfactory signal transmission from the olfactory receptors to the brain.
Illustrate the biochemical cascade triggered by odorant binding to olfactory receptors, including the role of G-proteins and second messengers in generating an action potential.
Identify different types of olfactory disorders such as anosmia, hyposmia, hyperosmia, and dysosmia, including their potential causes.
Key Topics:
Olfactory Genes:
3% of the human genome accounts for olfactory genes.
400 genes for odorant receptors.
Olfactory Membrane:
Located in the superior part of the nasal cavity.
Medially: Folds downward along the superior septum.
Laterally: Folds over the superior turbinate and upper surface of the middle turbinate.
Total surface area: 5-10 square centimeters.
Olfactory Mucosa:
Olfactory Cells: Bipolar nerve cells derived from the CNS (100 million), with 4-25 olfactory cilia per cell.
Sustentacular Cells: Produce mucus and maintain ionic and molecular environment.
Basal Cells: Replace worn-out olfactory cells with an average lifespan of 1-2 months.
Bowman’s Gland: Secretes mucus.
Stimulation of Olfactory Cells:
Odorant dissolves in mucus and attaches to receptors on olfactory cilia.
Involves a cascade effect through G-proteins and second messengers, leading to depolarization and action potential generation in the olfactory nerve.
Quality of a Good Odorant:
Small (3-20 Carbon atoms), volatile, water-soluble, and lipid-soluble.
Facilitated by odorant-binding proteins in mucus.
Membrane Potential and Action Potential:
Resting membrane potential: -55mV.
Action potential frequency in the olfactory nerve increases with odorant strength.
Adaptation Towards the Sense of Smell:
Rapid adaptation within the first second, with further slow adaptation.
Psychological adaptation greater than receptor adaptation, involving feedback inhibition from the central nervous system.
Primary Sensations of Smell:
Camphoraceous, Musky, Floral, Pepperminty, Ethereal, Pungent, Putrid.
Odor Detection Threshold:
Examples: Hydrogen sulfide (0.0005 ppm), Methyl-mercaptan (0.002 ppm).
Some toxic substances are odorless at lethal concentrations.
Characteristics of Smell:
Odor blindness for single substances due to lack of appropriate receptor protein.
Behavioral and emotional influences of smell.
Transmission of Olfactory Signals:
From olfactory cells to glomeruli in the olfactory bulb, involving lateral inhibition.
Primitive, less old, and new olfactory systems with different path
- Video recording of this lecture in English language: https://youtu.be/lK81BzxMqdo
- Video recording of this lecture in Arabic language: https://youtu.be/Ve4P0COk9OI
- Link to download the book free: https://nephrotube.blogspot.com/p/nephrotube-nephrology-books.html
- Link to NephroTube website: www.NephroTube.com
- Link to NephroTube social media accounts: https://nephrotube.blogspot.com/p/join-nephrotube-on-social-media.html
New Drug Discovery and Development .....NEHA GUPTA
The "New Drug Discovery and Development" process involves the identification, design, testing, and manufacturing of novel pharmaceutical compounds with the aim of introducing new and improved treatments for various medical conditions. This comprehensive endeavor encompasses various stages, including target identification, preclinical studies, clinical trials, regulatory approval, and post-market surveillance. It involves multidisciplinary collaboration among scientists, researchers, clinicians, regulatory experts, and pharmaceutical companies to bring innovative therapies to market and address unmet medical needs.
micro teaching on communication m.sc nursing.pdfAnurag Sharma
Microteaching is a unique model of practice teaching. It is a viable instrument for the. desired change in the teaching behavior or the behavior potential which, in specified types of real. classroom situations, tends to facilitate the achievement of specified types of objectives.
NVBDCP.pptx Nation vector borne disease control programSapna Thakur
NVBDCP was launched in 2003-2004 . Vector-Borne Disease: Disease that results from an infection transmitted to humans and other animals by blood-feeding arthropods, such as mosquitoes, ticks, and fleas. Examples of vector-borne diseases include Dengue fever, West Nile Virus, Lyme disease, and malaria.
New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...i3 Health
i3 Health is pleased to make the speaker slides from this activity available for use as a non-accredited self-study or teaching resource.
This slide deck presented by Dr. Kami Maddocks, Professor-Clinical in the Division of Hematology and
Associate Division Director for Ambulatory Operations
The Ohio State University Comprehensive Cancer Center, will provide insight into new directions in targeted therapeutic approaches for older adults with mantle cell lymphoma.
STATEMENT OF NEED
Mantle cell lymphoma (MCL) is a rare, aggressive B-cell non-Hodgkin lymphoma (NHL) accounting for 5% to 7% of all lymphomas. Its prognosis ranges from indolent disease that does not require treatment for years to very aggressive disease, which is associated with poor survival (Silkenstedt et al, 2021). Typically, MCL is diagnosed at advanced stage and in older patients who cannot tolerate intensive therapy (NCCN, 2022). Although recent advances have slightly increased remission rates, recurrence and relapse remain very common, leading to a median overall survival between 3 and 6 years (LLS, 2021). Though there are several effective options, progress is still needed towards establishing an accepted frontline approach for MCL (Castellino et al, 2022). Treatment selection and management of MCL are complicated by the heterogeneity of prognosis, advanced age and comorbidities of patients, and lack of an established standard approach for treatment, making it vital that clinicians be familiar with the latest research and advances in this area. In this activity chaired by Michael Wang, MD, Professor in the Department of Lymphoma & Myeloma at MD Anderson Cancer Center, expert faculty will discuss prognostic factors informing treatment, the promising results of recent trials in new therapeutic approaches, and the implications of treatment resistance in therapeutic selection for MCL.
Target Audience
Hematology/oncology fellows, attending faculty, and other health care professionals involved in the treatment of patients with mantle cell lymphoma (MCL).
Learning Objectives
1.) Identify clinical and biological prognostic factors that can guide treatment decision making for older adults with MCL
2.) Evaluate emerging data on targeted therapeutic approaches for treatment-naive and relapsed/refractory MCL and their applicability to older adults
3.) Assess mechanisms of resistance to targeted therapies for MCL and their implications for treatment selection
MANAGEMENT OF ATRIOVENTRICULAR CONDUCTION BLOCK.pdfJim Jacob Roy
Cardiac conduction defects can occur due to various causes.
Atrioventricular conduction blocks ( AV blocks ) are classified into 3 types.
This document describes the acute management of AV block.
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Ve...kevinkariuki227
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Verified Chapters 1 - 19, Complete Newest Version.pdf
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Verified Chapters 1 - 19, Complete Newest Version.pdf
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Ve...
Propanil Poisoning.pptx
1. PROPANIL POISONING
Dr KTD Priyadarshani
Registrar in Emergency Medicine
Teaching Hospital- Peradeniya
2023/04/18
2. SCOPE
Overview
Mechanism of toxic effects
Kinetics in overdose
Clinical effects
Investigations
Management
3. OVERVIEW
Selective herbicide
Used in paddy cultivation
Commercial product 36-48% propanil
Self poisoning with large doses , methemoglobinemia
is caused ,the case fatality can be as high as 10%
4. MECHANISM OF TOXIC EFFECTS
Propanil (3,4-dichloropropioanilide) is hydrolyzed in vivo to 3,4-dichloroaniline
Metabolized to other compounds, including 3,4-dichlorophenylhydroxylamine
Toxicity is induced primarily by the 3,4-dichlorophenylhydroxylamine metabolite
induces cellular dysfunction through formation of free radicals and depletion of intracellular glutathione
stores
The major apparent biochemical
production of metHb by oxidation of the ferrous haem (Fe2+ ) in erythrocytes to the ferric state (Fe3+ )
MetHb is unable to bind and transport oxygen in the vascular system
5.
6. KINETICS IN OVERDOSE
Absorption
No human data are available
But sufficient propanil is absorbed with oral exposures to produce severe toxicity and death
Distribution
No human data are available.
Propanil or its metabolites appear to have a long plasma half-life
the clinical effects of metHb are prolonged for a number of days
7. CLINICAL EFFECTS
Noted within six hours of ingestion of propanil
Principle effect being metHb
When poisoning is severe there may be an altered level of consciousness, lactic acidosis,
hypotension and hypoventilation secondary to tissue hypoxia
Mortality rate is 12% in some series,
8. Gastrointestinal
effects
Pulmonary effects Cardiac effects Central nervous
system effects
Metabolic effects
Nausea,
vomiting and
diarrhea
Dyspnea
Hyperventilatio
n
Followed by
hypoventilation
and hypoxemia
with severe
poisoning
Tachycardia,
hypotension
and ischemic
changes on
ECG may occur
with severe
poisoning
Headache,
dizziness,
syncope,
confusion,
sedation, coma
and seizures
metabolic
acidosis with an
elevated lactate
(severe
poisoning)
10. DETERMINATION OF SEVERITY
The assessment of severity of toxicity is determined by clinical grading of toxicity
Clinical evidence of cyanosis, with ‘chocolate brown’ colored blood on white filter paper is
suggestive of severe propanil poisoning
This can be quantified at the bedside using a simple bedside color chart
11.
12.
13. INVESTIGATIONS
ABG
Arterial blood gases (including metHb and lactate measurements) are the most important investigations for
diagnosis and monitoring
Elevations in metHb are noted within a few hours of poisoning and may continue to rise beyond 6h
In the absence of resources to directly measure metHb concentrations, the diagnosis is suspected
when;
low saturations on pulse oximetry
despite a normal or elevated pO2 on arterial blood gas
14. INVESTIGATIONS
Once metHb is diagnosed, serial venous lactate measurements may be useful to monitor the
course of poisoning (including response to antidotes)
Serum electrolytes, creatinine, urea, liver function tests, cardiac enzymes and glucose should
also be measured
ECG
All patients with significant metHb or acidemia should have a baseline ECG to detect silent ischemia
CXR
Pulmonary involvement
TRALI
15. MANAGEMENT
Gastric lavage if <2h (given the airway is protected )
Adequate hydration
Strict bed rest
If cyanosis and/or impaired respiration is observed , give 100% oxygen
Assisted ventilation may be necessary
Normoglycemia
since adequate glucose concentrations are required by the reducing enzymes present in erythrocytes and
the antidote methylene blue
16. ANTIDOTE
Methylene blue is commonly used first line
No clinical studies
N-acetylcysteine (NAC) or ascorbic acid (Vitamin C) may also reverse metHb
although very high doses were required
considered in patients with severe propanil poisoning unresponsive to methylene blue, or where methylene
blue is unavailable
17. METHYLENE BLUE
Methyl-thionium chloride
The standard antidote for reversal of metHb
First line antidote in acute symptomatic propanil
poisoning
Propanil appears to produce prolonged and recurrent
MetHb
methylene blue may be more effective if administered as an
infusion following the initial bolus
18.
19. Moderate
poisoning
• 1mg/kg methylene blue as a bolus injection over 1
minute
• Reassess MetHb after one hour
• Repeat Methylene blue if toxicity persists
Severe
poisoning
• 2mg/kg methylene blue as a bolus injection over 1
minute
• followed by an infusion of 10 mg/hour for 10 hours
• Reassess metHb concentration within one hour of
commencement of the infusion
• If metHb > 20%,
• a further bolus injection of 2 mg/kg
• the infusion rate increased by 50%.
• If metHb < 20% then the infusion is maintained at the
the current rate
20. The maximum recommended daily dose of methylene blue is
7mg/kg, but toxicity has also been reported following doses of
4mg/kg
Adverse effects from methylene blue;
nausea, vomiting, diaphoresis, burning sensation of the mouth and
fingers and abdominal pain
Severe toxicity is also reported, including hypotension,
exacerbation of MetHb and hemolysis
Methylene blue should not be administered to patients with G6PD
deficiency because;
it is minimally effective
may exacerbate the degree of MetHb
induce hemolysis
21. N-acetylcysteine
antioxidant
donates sulfhydryl groups
replacing depleted intracellular glutathione stores
Empirically used in patients with moderate to severe propanil poisoning that is refractory to
methylene blue, or where methylene blue is unavailable
Given the potential for hypotension and respiratory distress with severe propanil poisoning
150mg/kg NAC over 4h, then
50mg/kg NAC over 4h, then
100mg/kg NAC over 16h. This infusion should be repeated until the patient has recovered.
22. Ascorbic acid (Vitamin C)
an antioxidant that scavenges free radicals ,minimizing the formation of
metHb
Oral ascorbic acid has been administered when methylene blue was
unavailable
This may relate to the decrease in bioavailability with increasing doses of
oral ascorbic acid.
Empirically used in patients with moderate to severe propanil poisoning
that is refractory to methylene blue
intravenous ascorbic acid 2g infused over 24h is associated with limited
toxicity
23. OTHER METHODS
Toluidine Blue-
Only data available for Meth HB induced by 4-dimethylaminophenol-induced Meth
Hb
Bolus 2mg/kg was 80% more effective than methylene blue and without side effects
Exchange transfusion is life saving in severe poisoning not responding to
above drugs